Latest Articles

The role of psychological care in the treatment of gynecological disorders in girls and young women - an interdisciplinary perspective.

This review article explores the psychological dimension of gynecological disorders in girls and young women, emphasizing the need for interdisciplinary approaches in medical care. Gynecological conditions such as endometriosis, polycystic …

MYC: unveiling novel therapeutic avenues for endometriosis.

Catheter-Directed Sclerotherapy Versus Ovarian Cystectomy for Unilateral Ovarian Endometrioma: A Pilot Randomized Controlled Trial.

Background: Ovarian cystectomy is standard treatment for endometrioma but is associated with decreased ovarian reserve. Catheter-directed sclerotherapy (CDS) is an ovary-sparing image-guided alternative; however, supporting evidence comprises retrospective comparative and …

Women's Health Firms Aim for Earlier Endometriosis Diagnoses Through Menstrual Blood, Multiomics - GenomeWeb

Women's Health Firms Aim for Earlier Endometriosis Diagnoses Through Menstrual Blood, Multiomics GenomeWeb

Absci forms advisory board for endometriosis drug program - Investing.com

Absci forms advisory board for endometriosis drug program Investing.com

Local MP Suella Braverman hits out over trans charity role - Meon Valley Times

Local MP Suella Braverman hits out over trans charity role Meon Valley Times

General Hospital's Kate Mansi says life-saving surgery performed by her stepdad led to endometriosis diagnosis (exclusive) - MSN

General Hospital's Kate Mansi says life-saving surgery performed by her stepdad led to endometriosis diagnosis (exclusive) MSN

NEWS CENTER Maine at 11 PM - newscentermaine.com

NEWS CENTER Maine at 11 PM newscentermaine.com

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire